NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $352,721 | -90.8% | 5,865 | -88.8% | 0.01% | -87.9% |
| Q4 2022 | $3,833,711 | +12.9% | 52,266 | +16.9% | 0.07% | +13.8% |
| Q3 2022 | $3,397,000 | -49.5% | 44,705 | -44.9% | 0.06% | -55.7% |
| Q1 2022 | $6,723,000 | +122.3% | 81,151 | +101.5% | 0.13% | +65.8% |
| Q4 2021 | $3,024,000 | -22.7% | 40,282 | +19.7% | 0.08% | +9.7% |
| Q3 2021 | $3,910,000 | +45.1% | 33,658 | +177.1% | 0.07% | +46.9% |
| Q2 2021 | $2,694,000 | – | 12,145 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |